Cellistic
  • Platforms
    • Pulse
    • Echo
      • Echo - NK
  • Allo Chassis™
  • Our Approach
    • Donor-Derived Allogeneic
    • iPSC-Based Allogeneic
    • Autologous
  • News & Events
    • Insights
    • Events
  • About
    • Team
    • Facility
    • Careers
  • Contact

Interviews

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Expert Opinion: Suzanne Snellenberg, PhD

July 18, 2023

Expert Opinion: Suzanne Snellenberg, PhD

Editor's note: In this installment of Expert Opinion, Suzanne Snellenberg, PhD, Director of ...

Sustaining momentum in iPSC-derived allogeneic cell therapies

March 30, 2023

Sustaining momentum in iPSC-derived allogeneic cell therapies

As published in Drug Target Review - March/April 2023 Issue Drug Target Review connects with ...

iPSCs in the cell therapy landscape: Interview with Elena Matsa

January 30, 2023

iPSCs in the cell therapy landscape: Interview with Elena Matsa

How has the cell therapy landscape evolved in the past ten years, particularly in regard to ...

The value of capability in allogeneic cell therapy: an interview with Andy Holt

January 16, 2023

The value of capability in allogeneic cell therapy: an interview with Andy ...

In this interview, we spoke to Andy about Cellistic’s recent acquisition of a GMP facility and ...

Expert Opinion: Benjamin Demoulin, PhD

January 10, 2023

Expert Opinion: Benjamin Demoulin, PhD

Editor's note: In this installment of Expert Opinion, Benjamin Demoulin, PhD, Director of Cell ...

Expert Opinion: Elena Matsa, PhD

November 17, 2022

Expert Opinion: Elena Matsa, PhD

Editor’s Note: In this installment of Expert Opinion, Elena Matsa, PhD, VP of Cell Technology ...

Cellistic

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium BE-Belgium-Flag

partnering@cellistic.com

  • Platforms
  • Allo Chassis™
  • Our Approach
  • News & Events
  • About
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Team
  • Careers
X twitter x-twitter Linkedin